Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UNIVERSAL2: DRV/r FDC in Children with HIV
NCT06139796Phase 2Withdrawn
- Sponsor
- Penta Foundation
- Start
- Feb 2025
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of darunavir, ritonavir in human immunodeficiency virus infection (HIV), sponsored by Penta Foundation. Planned start Feb 2025; status: withdrawn.
02
Drugs
darunavirritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT06139796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06139796.